Acacia Pharma Group plc

Gamida Cell is nearing an expected US approval of its “breakthrough” allogeneic hematopoietic stem cell transplant (allo-HSCT) therapy omidubicel – but a lack of money could undermine its chances of

Just over a month after getting US approval for Zoryve, a topical cream for psoriasis, Arcutis Biotherapeutics, Inc. is now targeting atopic dermatitis with the proposed purchase of the UK's Ducent

Diurnal Group PLC 's dream to remain independent and become a fully integrated firm has failed to materialize, with the UK biotech being bought by Neurocrine Biosciences, Inc. of the US for £48.3m (

With the biotech bubble well and truly burst, promising European firms have joined the list of companies being forced to restructure in order to stay afloat as the cash runs out. The most recent is De